Found 288 articles for: "Case Report"
Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series
July 2026 | Volume 25 | Issue 7 | Case Reports | 659 | Copyright © July 2026
Background: Aromatase inhibitors (AIs) and anti-HER2 therapies improve breast cancer survival, but dermatologic adverse events (dAEs) are underrecognized despite affecting qualit...
Read MoreVitiligo Successfully Treated With Roflumilast Cream 0.3%
July 2026 | Volume 25 | Issue 7 | Case Reports | 662 | Copyright © July 2026
Vitiligo is an autoimmune cutaneous depigmenting disorder that can have significant psychological impacts on affected patients, posing a burden to daily life, which can be even more apparent in p...
Read MoreGeneralized Bullous Fixed-Drug Eruption in a 15-Year-Old Child With Becker Muscular Dystrophy and Epilepsy
June 2026 | Volume 25 | Issue 6 | Case Reports | 565 | Copyright © June 2026
Introduction: Generalized bullous fixed drug eruption (GBFDE) is a potentially life-threatening condition, typically triggered by a range of medications. Its incidence in the ped...
Read MoreResolution of Hand, Foot, and Mouth Disease With Valacyclovir
June 2026 | Volume 25 | Issue 6 | Case Reports | 562 | Copyright © June 2026
Hand, foot, and mouth disease (HFMD) is a common viral illness that predominantly affects young children, with approximately 95% of cases occurring in individuals under the age of 5. While typica...
Read MoreTreatment of Confluent and Reticulated Papillomatosis Using Fixed-Dose Clindamycin phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel
May 2026 | Volume 25 | Issue 5 | Case Reports | 474 | Copyright © May 2026
Introduction: Confluent and reticulated papillomatosis (CARP) is a rare, non-systemic disease usually treated using oral antibiotics.Case Presentation:Read MorePembrolizumab as an Off-Label Treatment of Facial Angiosarcoma: A Case Report
May 2026 | Volume 25 | Issue 5 | Case Reports | 471 | Copyright © May 2026
Summary of Case: We report an atypical case of cutaneous angiosarcoma presenting as unilateral nasal swelling in an elderly male. The lesion was unresponsive to topical and antib...
Read MoreSuccessful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib
April 2026 | Volume 25 | Issue 4 | Case Reports | 384 | Copyright © April 2026
Introduction: JAK inhibitors are increasingly being utilized for the treatment of diseases beyond their nonclassical indications, and thehighly selective JAK1 inhibi...
Read MoreRapid Clearance of Lichen Planus With Topical Tapinarof
April 2026 | Volume 25 | Issue 4 | Case Reports | 381 | Copyright © April 2026
Background: Lichen planus (LP) is an auto-inflammatory idiopathic condition affecting skin, mucous membranes, hair follicles, and nails that presents as pruritic, violaceous papu...
Read MoreFrom Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy
March 2026 | Volume 25 | Issue 3 | Case Reports | 273 | Copyright © March 2026
Introduction: Alopecia areata (AA) is an autoimmune condition marked by non-scarring, patchy hair loss of the scalp which progresses in <10% of cases to alopecia totalis (AT),...
Read MoreAmelioration of Dominant Dystrophic Epidermolysis Bullosa Ulceration by Combination Gentian Violet and Trichloroacetic Acid Therapy
February 2026 | Volume 25 | Issue 2 | Case Reports | 175 | Copyright © February 2026
Introduction: Dominant dystrophic epidermolysis bullosa (DDEB) is a hereditary genetic disorder with a mutation of the type VII collagen gene (COL7A1), leading to a destabilized ...
Read MorePhotodistributed Hyperpigmentation Associated With COVID-19 Vaccination
January 2026 | Volume 25 | Issue 1 | Case Reports | 93 | Copyright © January 2026
Background: Although drugs are a common cause of hyperpigmentation, the pathogenesis is unclear and varies based on the offending agent. Classic medications associated with hyper...
Read MoreHalo Seborrheic Keratosis in a Patient of Color With Vitiligo
January 2026 | Volume 25 | Issue 1 | Case Reports | 95 | Copyright © January 2026
A 73-year-old woman with Fitzpatrick skin type V presented with a long-standing brownish-black, three-tone macule on the right anterior thigh that developed a sharply demarcated depigmented halo....
Read MoreResolution of Lichen Simplex Chronicus With Nemolizumab: A Case Report
December 2025 | Volume 24 | Issue 12 | Case Reports | 1252 | Copyright © December 2025
Introduction: Lichen simplex chronicus is a debilitating condition characterized by lichenified skin secondary to intractable itch. Lichen simplex chronicus is challenging to tre...
Read MorePyoderma Gangrenosum Following Total Colectomy for Ulcerative Colitis
December 2025 | Volume 24 | Issue 12 | Case Reports | 1254 | Copyright © December 2025
Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib
November 2025 | Volume 24 | Issue 11 | | 1138 | Copyright © November 2025
Primary biliary cholangitis (PBC) can present with overlapping features of limited systemic sclerosis, commonly known as calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, a...
Read MoreManagement of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream
November 2025 | Volume 24 | Issue 11 | | 1141 | Copyright © November 2025
Introduction: Benign Familial Pemphigus (Hailey-Hailey Disease [HHD]) is a rare chronic condition, with treatments focusing on managing disease symptoms.Case...
Read MoreThe Role of Simultaneous Janus Kinase Inhibitor and Biologic Therapy Use for Refractory Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Case Reports | 1043 | Copyright © October 2025
Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report
October 2025 | Volume 24 | Issue 10 | Case Reports | 1041 | Copyright © October 2025
Post-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management
September 2025 | Volume 24 | Issue 9 | Case Reports | 938 | Copyright © September 2025
Background: Alopecia universalis (AU) is the most severe form of alopecia areata (AA), characterized by complete scalp and body hair loss. While post-COVID-19 hair loss is often ...
Read MoreHypochlorous Acid for a Persistent Filler Nodule: A Case Report
September 2025 | Volume 24 | Issue 9 | Case Reports | 934 | Copyright © September 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
